These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29661826)

  • 1. Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin.
    Marangoni F; Zhang R; Mani V; Thelen M; Ali Akbar NJ; Warner RD; Äijö T; Zappulli V; Martinez GJ; Turka LA; Mempel TR
    J Immunol; 2018 May; 200(10):3647-3661. PubMed ID: 29661826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.
    Marangoni F; Zhakyp A; Corsini M; Geels SN; Carrizosa E; Thelen M; Mani V; Prüßmann JN; Warner RD; Ozga AJ; Di Pilato M; Othy S; Mempel TR
    Cell; 2021 Jul; 184(15):3998-4015.e19. PubMed ID: 34157302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses.
    Zaitsu M; Issa F; Hester J; Vanhove B; Wood KJ
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
    Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2.
    Hombach AA; Kofler D; Hombach A; Rappl G; Abken H
    J Immunol; 2007 Dec; 179(11):7924-31. PubMed ID: 18025240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development.
    Vang KB; Yang J; Pagán AJ; Li LX; Wang J; Green JM; Beg AA; Farrar MA
    J Immunol; 2010 Apr; 184(8):4074-7. PubMed ID: 20228198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B Cells Drive Autoimmunity in Mice with CD28-Deficient Regulatory T Cells.
    Zhang R; Sage PT; Finn K; Huynh A; Blazar BR; Marangoni F; Mempel TR; Sharpe AH; Turka LA
    J Immunol; 2017 Dec; 199(12):3972-3980. PubMed ID: 29093061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors.
    Lio CW; Dodson LF; Deppong CM; Hsieh CS; Green JM
    J Immunol; 2010 Jun; 184(11):6007-13. PubMed ID: 20421644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
    Vogel I; Verbinnen B; Van Gool S; Ceuppens JL
    J Immunol; 2016 Jul; 197(2):533-40. PubMed ID: 27288533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory Rebound in IL-12-Treated Tumors Is Driven by Uncommitted Peripheral Regulatory T Cells.
    Li Q; Virtuoso LP; Anderson CD; Egilmez NK
    J Immunol; 2015 Aug; 195(3):1293-300. PubMed ID: 26085681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 is required for the induction of high dose oral tolerance.
    Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y
    Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
    Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
    Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse and human CD8(+) CD28(low) regulatory T lymphocytes differentiate in the thymus.
    Vuddamalay Y; Attia M; Vicente R; Pomié C; Enault G; Leobon B; Joffre O; Romagnoli P; van Meerwijk JP
    Immunology; 2016 Jun; 148(2):187-96. PubMed ID: 26924728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.